Nausea

Neurology·MeSH: Nausea

25 drugs in development·17 companies·3 clinical trials

Drug Pipeline by Phase

Approved(13)

Drug	Company
aponvie	HERON THERAPEUTICS, INC. /DE/ (HRTX)
aprepitant	Mylan II B.V. (MYL)
cannabis	One World Products, Inc. (OWPC)
cinvanti	HERON THERAPEUTICS, INC. /DE/ (HRTX)
granisetron	Sana Biotechnology, Inc. (SANA)
granisetron	Amneal Pharmaceuticals, Inc. (AMRX)
Ondif® (licensed product)	Aquestive Therapeutics, Inc. (AQST)
palonosetron	Teva Pharmaceutical Industries Limited (TEVA)
perphenazine	Mylan II B.V. (MYL)
prochlorperazine edisylate	NEXUS BIOPHARMA INC (NEXS)
sustol	HERON THERAPEUTICS, INC. /DE/ (HRTX)
syndros	Insys Therapeutics, Inc. (INSY)
varubi	TESARO, Inc. (TSRO)

Phase 3(5)

Drug	Company
apf530	HERON THERAPEUTICS, INC. /DE/ (HRTX)
fosaprepitant	HERON THERAPEUTICS, INC. /DE/ (HRTX)
palonosetron	HERON THERAPEUTICS, INC. /DE/ (HRTX)
tak-951	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-951	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

Phase 2(2)

Drug	Company
Background Chemotherapy	ELI LILLY & Co (LLY)
LY3537021	ELI LILLY & Co (LLY)

Preclinical(3)

Phase 4(2)

Drug	Company
Dexamedomedine	COGNITION THERAPEUTICS INC (CGTX)
pantoprazole	UNITED THERAPEUTICS Corp (UTHR)

BioSniper tracks 25 drugs in development for Nausea across 17 companies.

There are 3 clinical trials targeting Nausea tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.